{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T01:08:33Z","timestamp":1773450513253,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s40001-015-0182-9","type":"journal-article","created":{"date-parts":[[2015,10,21]],"date-time":"2015-10-21T15:25:16Z","timestamp":1445441116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["PALB2 mutations in breast cancer patients from a multi-ethnic region in northwest China"],"prefix":"10.1186","volume":"20","author":[{"given":"Yong Tao","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei Hua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming Shuai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng Guang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li Na","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulati","family":"WuwaliKhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisikaer","family":"Ayoufu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang Hua","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,21]]},"reference":[{"key":"182_CR1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2217\/fon.12.61","volume":"8","author":"JR Benson","year":"2012","unstructured":"Benson JR, Jatoi I. The global breast cancer burden. Future Oncol. 2012;8:697\u2013702.","journal-title":"Future Oncol"},{"key":"182_CR2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature11017","volume":"486","author":"PJ Stephens","year":"2012","unstructured":"Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, Wedge DC, et al. The landscape of cancer genes and mutational processes in breast cancer. Nature. 2012;486:400\u20134.","journal-title":"Nature"},{"key":"182_CR3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.genom.9.081307.164339","volume":"9","author":"C Turnbull","year":"2008","unstructured":"Turnbull C, Rahman N. Genetic predisposition to breast cancer: past, present, and future. Annu Rev Genomics Hum Genet. 2008;9:321\u201345.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"182_CR4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/GCO.0b013e328332dca3","volume":"22","author":"AW Kurian","year":"2010","unstructured":"Kurian AW. BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications. Curr Opin Obstet Gynecol. 2010;22:72\u20138.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"182_CR5","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1158\/0008-5472.CAN-10-1012","volume":"70","author":"M Tischkowitz","year":"2010","unstructured":"Tischkowitz M, Xia B. PALB2\/FANCN: recombining Cancer and Fanconi anemia. Cancer Res. 2010;70:7353\u20139.","journal-title":"Cancer Res"},{"key":"182_CR6","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3109\/09553002.2012.711500","volume":"88","author":"M Frankenberg-Schwager","year":"2012","unstructured":"Frankenberg-Schwager M, Gregus A. Chromosoma instability induced by mammography X-rays in primary human fibroblasts from BRCA1 and BRCA2 mutation carriers. Int J Radiat Biol. 2012;88:846\u201357.","journal-title":"Int J Radiat Biol"},{"key":"182_CR7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1042\/BJ20140208","volume":"3","author":"J Pauty","year":"2014","unstructured":"Pauty J, Rodrigue A, Couturier A, Buisson R, Masson JY. Exploring the roles of PALB2 at the crossroads of DNA repair and cancer. Biochem J. 2014;3:331\u201342.","journal-title":"Biochem J"},{"key":"182_CR8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.gde.2010.02.009","volume":"20","author":"A Hollestelle","year":"2010","unstructured":"Hollestelle A, Wasielewski M, Martens JW, Schutte M. Discovering moderate-risk breast cancer susceptibility genes. Curr Opin Genet Dev. 2010;20:268\u201376.","journal-title":"Curr Opin Genet Dev"},{"key":"182_CR9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa1400382","volume":"6","author":"AC Antoniou","year":"2014","unstructured":"Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylk\u00e4s K, Roberts J, et al. Breast-cancer risk in families with mutations in PALB2. N Engl J Med. 2014;6:497\u2013506.","journal-title":"N Engl J Med"},{"key":"182_CR10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10549-008-0036-z","volume":"114","author":"AY Cao","year":"2009","unstructured":"Cao AY, Huang J, Hu Z, Li WF, Ma ZL, Tang LL, et al. The prevalence of PALB2 germline mutations in BRCA1\/BRCA2 negative Chinese women with early onset breast cancer or affected relatives. Breast Cancer Res Treat. 2009;114:457\u201362.","journal-title":"Breast Cancer Res Treat"},{"key":"182_CR11","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1158\/1078-0432.CCR-08-0429","volume":"14","author":"P Chen","year":"2008","unstructured":"Chen P, Liang J, Wang Z, Zhou X, Chen L, Li M, et al. Association of common PALB2 polymorphisms with breast cancer risk: a case-control study. Clin Cancer Res. 2008;14:5931\u20137.","journal-title":"Clin Cancer Res"},{"key":"182_CR12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4048\/jbc.2013.16.1.50","volume":"16","author":"Ou Jianghua","year":"2013","unstructured":"Jianghua Ou, Tao Wu, Sijmons Rolf, Ni Duo, Wenting Xu, Upur Halmurat. Prevalence of BRCA1 and BRCA2 germline mutations in breast cancer women of multiple ethnic region in northwest China. J Breast Cancer. 2013;16:50\u20134.","journal-title":"J Breast Cancer"},{"key":"182_CR13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/2047-783X-19-35","volume":"19","author":"YT Li","year":"2014","unstructured":"Li YT, Ni D, Yang L, Zhao Q, Ou JH. The prevalence of BRCA1\/2 mutations of triple-negative breast cancer in Xinjing multiple ethnic region of China. Eur J Med Res. 2014;19:35.","journal-title":"Eur J Med Res"},{"key":"182_CR14","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1158\/0008-5472.CAN-10-3958","volume":"6","author":"S Casadei","year":"2011","unstructured":"Casadei S, Norquist BM, Walsh T, Stray S, Mandell JB, Lee MK, et al. Contribution of inherited mutations in the BRCA2- interacting protein PALB2 to familial breast cancer. Cancer Res. 2011;6:2222\u20139.","journal-title":"Cancer Res"},{"key":"182_CR15","first-page":"7155","volume":"17","author":"SM Sy","year":"2009","unstructured":"Sy SM, Huen MS, Chen J. PALB2 is an integral component of the BRCA complex required for homologous recombination repair. Proc Natl Acad Sci USA. 2009;17:7155\u201360.","journal-title":"Proc Natl Acad Sci USA"},{"key":"182_CR16","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cub.2009.02.018","volume":"6","author":"F Zhang","year":"2009","unstructured":"Zhang F, Ma J, Wu J, Ye L, Cai H, Xia B, et al. PALB2 links BRCA1 and BRCA2 in the DNA-damage response. Curr Biol. 2009;6:524\u20139.","journal-title":"Curr Biol"},{"key":"182_CR17","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10549-011-1443-0","volume":"3","author":"MW Wong","year":"2011","unstructured":"Wong MW, Nordfors C, Mossman D, Pecenpetelovska G, Avery-Kiejda KA, Talseth-Palmer B, et al. BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer. Breast Cancer Res Treat. 2011;3:853\u20139.","journal-title":"Breast Cancer Res Treat"},{"key":"182_CR18","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10549-010-1290-4","volume":"2","author":"N Bogdanova","year":"2011","unstructured":"Bogdanova N, Sokolenko AP, Iyevleva AG, Abysheva SN, Blaut M, Bremer M, et al. PALB2 mutations in German and Russian patients with bilateral breast cancer. Breast Cancer Res Treat. 2011;2:545\u201350.","journal-title":"Breast Cancer Res Treat"},{"key":"182_CR19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s10549-010-1305-1","volume":"3","author":"P Peterlongo","year":"2011","unstructured":"Peterlongo P, Catucci I, Pasquini G, Verderio P, Peissel B, Barile M, et al. PALB2 germline mutations in familial breast cancer cases with personal and family history of pancreatic cancer. Breast Cancer Res Treat. 2011;3:825\u20138.","journal-title":"Breast Cancer Res Treat"},{"key":"182_CR20","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1158\/0008-5472.CAN-10-3958","volume":"6","author":"S Casadei","year":"2011","unstructured":"Casadei S, Norquist BM, Walsh T, Stray S, Mandell JB, Lee MK, et al. Contribution of inherited mutations in the BRCA2 interacting protein PALB2 to familial breast cancer. Cancer Res. 2011;6:2222\u20139.","journal-title":"Cancer Res"},{"key":"182_CR21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2350-11-20","volume":"11","author":"A Dansonka-Mieszkowska","year":"2010","unstructured":"Dansonka-Mieszkowska A, Kluska A, Moes J, Dabrowska M, Now-Akowska D, Niwinska A, et al. A novel germline PALB2 deletion in Polish breast and ovarian cancer patients. BMC Med Gene. 2010;11:20.","journal-title":"BMC Med Gene"},{"key":"182_CR22","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1158\/0008-5472.CAN-10-3958","volume":"6","author":"Silvia Casadei","year":"2011","unstructured":"Casadei Silvia, Norquist Barbara M, Walsh Tom, Stray Sunday, Mandell Jessica B, Lee Ming K, et al. Contribution of Inherited Mutations in the BRCA2-Interacting Protein PALB2 to Familial Breast Cancer. Cancer Res. 2011;6:2222\u20139.","journal-title":"Cancer Res"},{"key":"182_CR23","first-page":"R17","volume":"1","author":"ZL Teo","year":"2013","unstructured":"Teo ZL, Park DJ, Provenzano E, Chatfield CA, Odefrey FA, Nguyen-Dumont T, et al. Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families. Breast Cancer Res. 2013;1:R17.","journal-title":"Breast Cancer Res"},{"key":"182_CR24","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/humu.22022","volume":"4","author":"M Tischkowitz","year":"2012","unstructured":"Tischkowitz M, Capanu M, Sabbaghian N, Li L, Liang X, Vall\u00e9e MP, et al. Rare germline mutations in PALB2 and breast cancer risk: a population-based study. Hum Mutat. 2012;4:674\u201380.","journal-title":"Hum Mutat"},{"key":"182_CR25","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","volume":"6559","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identifcation of the breast cancer susceptibility gene BRCA2. Nature. 1995;6559:789\u201392.","journal-title":"Nature"},{"key":"182_CR26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10549-009-0673-x","volume":"1","author":"A Sauty de Chalon","year":"2010","unstructured":"Sauty de Chalon A, Teo Z, Park DJ, Odefrey FA, kConFab, Hopper JL, et al. Are PALB2 mutations associated with increased risk of male breast cancer? Breast Cancer Res Treat. 2010;1:253\u20135.","journal-title":"Breast Cancer Res Treat"},{"key":"182_CR27","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1158\/1078-0432.CCR-08-3128","volume":"9","author":"T Heikkinen","year":"2009","unstructured":"Heikkinen T, K\u00e4rkk\u00e4inen H, Aaltonen K, Milne RL, Heikkil\u00e4 P, Aittom\u00e4ki K, et al. The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype. Clin Cancer Res. 2009;9:3214\u201322.","journal-title":"Clin Cancer Res"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-015-0182-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T15:34:23Z","timestamp":1567265663000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurjmedres.com\/content\/20\/1\/85"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,21]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["182"],"URL":"https:\/\/doi.org\/10.1186\/s40001-015-0182-9","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,21]]},"article-number":"85"}}